Clinical equivalence of evolocumab among patient subgroups in PROFICIO: a pooled analysis of 3146 patients from phase 3 studies

被引：0
|
作者：
Stroes, E. [1 ]
Robinson, J. [2 ,3 ]
Raal, F. [4 ]
Dufour, R. [5 ]
Sullivan, D. [6 ]
Blagden, M. [7 ]
Kassahun, H. [8 ]
Yang, J. [9 ]
Wasserman, S. [9 ]
Koren, M. [10 ]
机构：
[1] Acad Med Ctr Amsterdam, Dept Vasc Med, Amsterdam, Netherlands
[2] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[3] Univ Iowa, Dept Med, Iowa City, IA 52242 USA
[4] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa
[5] Inst Rech Clin Montreal, Hypertens Clin, Montreal, PQ H2W 1R7, Canada
[6] Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia
[7] Avondale Surg, Chesterfield, England
[8] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
[10] Jacksonville Ctr Clin Res, Jacksonville, FL USA
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1756
引用
收藏
页码：307 / 308
页数：2
相关论文
共 50 条
  • [41] Alogliptin Use in the Elderly: A Pooled Analysis from Phase 2-3 Studies
    Pratley, Richard
    Mccall, Therese
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2009, 58 : A123 - A123
  • [42] Alogliptin use in the elderly: a pooled analysis from Phase 2-3 studies
    Pratley, R.
    McCall, T.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    DIABETOLOGIA, 2009, 52 : S301 - S302
  • [43] Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies
    Pratley, Richard E.
    McCall, Therese
    Fleck, Penny R.
    Wilson, Craig A.
    Mekki, Qais
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (11) : 2011 - 2019
  • [44] Omalizumab add-on therapy reduces exacerbations among responders: A pooled NNT analysis from 5 phase 3 studies
    Kasujee, Ismail
    Bader, Giovanni
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [45] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Mease, Philip J.
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela S.
    Helliwell, Philip
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [46] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Philip J. Mease
    Ana-Maria Orbai
    Oliver FitzGerald
    Mohamed Bedaiwi
    Rajiv Dona L. Fleishaker
    Pamela Mundayat
    Philip S. Young
    Arthritis Research & Therapy, 25
  • [47] Pooled Analysis of Safety from Birtamimab Phase 1-3 Studies in Patients with Light Chain (AL) Amyloidosis
    Sanchorawala, Vaishali
    Wechalekar, Ashutosh D.
    Kastritis, Efstathios
    Palladini, Giovanni
    Schoenland, Stefan
    Comenzo, Raymond
    D'Souza, Anita
    Khouri, Jack
    Jimenez-Zepeda, Victor
    Sprinz, Katherine Ingrid
    Hao, Heather
    Huang, Wenying
    Aubrey, Laura Governale
    Gertz, Morie A.
    BLOOD, 2023, 142
  • [48] Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    Nahas, Stephanie J.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    Silberstein, Stephen D.
    NEUROLOGY, 2020, 94 (15)
  • [49] Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies
    Vargas, Bert B.
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    McAllister, Peter
    NEUROLOGY, 2020, 94 (15)
  • [50] Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Diener, Hans Christoph
    McAllister, Peter
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Silberstein, Stephen D.
    CEPHALALGIA, 2022, 42 (08) : 769 - 780
12345